XML 22 R10.htm IDEA: XBRL DOCUMENT v3.24.3
PREPAID EXPENSES AND OTHER RECEIVABLES
 6 Months Ended
Sep. 30, 2024
Prepaid Expenses And Other Receivables  
PREPAID EXPENSES AND OTHER RECEIVABLES

NOTE 5. PREPAID EXPENSES AND OTHER RECEIVABLES

 

At September 30, 2024 and March 31, 2024, prepaid expenses and other receivables were comprised of the following (in thousands):

 

          
   September 30, 2024
(Unaudited)		  March 31, 2024
       
Prepaid clinical research costs  $–   $1,924 
Refund from Parexel   552    – 
Prepaid insurance   249    575 
Tax deposits   63    64 
Other prepaid expenses   26    65 
Other receivables   18    39 
Security deposit on office lease expiring in May 2025   14    – 
Total prepaid expenses and other receivables  $922   $2,667 

 

The decrease in prepaid expenses and other receivables from $2.7 million as of March 31, 2024 to $0.9 million as of September 30, 2024 is primarily attributable to periodic amortization of prepaid clinical research costs and insurance premiums and the write-off of $1.1 million of advances to Parexel International (IRL) Limited (“Parexel”), partially offset by a $0.6 million refund receivable from Paraxel as of September 30, 2024. Refer to the “iOx – Parexel Master Services Agreement” section of Note 12, “Commitments and Contingent Liabilities” for further discussion regarding this matter.